RE
LinkedIn

Rami Elghandour

Chairman & Chief Executive Officer

San Francisco Bay Area · 1 connection

Arcellx, Inc.

Not on Unlinked · Imported profile. Is this you? Claim it

About

Rami Elghandour is Chairman and CEO of Arcellx (NASDAQ: ACLX), a biotechnology company developing transformative immunotherapies for cancer and autoimmune diseases. Rami has led two successful IPOs, built two multibillion-dollar public companies, and raised more than $1.75 billion in capital. Since joining in 2021, Rami transformed Arcellx from a small, early-stage startup into a leading, commercial-ready organization. During his tenure, he advanced anito-cel, the best therapeutic option for multiple myeloma, and drove a more than fortyfold increase in value with its acquisition by Gilead for $8.2 billion in April 2026. Previously, Rami was President and CEO of Nevro Corporation (formerly NYSE: NVRO), a global medical device company. Rami scaled the company from 30 employees to nearly 1,000, increasing its value by more than tenfold and reaching a peak valuation of over $3 billion. Rami’s career has spanned research, investing, and leadership roles with a dedication to bringing innovative, best-in-class therapies to patients and clinicians. He started his career as a design engineer designing and developing implantable neurostimulators. As a venture capitalist with Johnson and John

Experience

Chairman & Chief Executive OfficerArcellx
Jan 2021
Member Board of DirectorsRoom to Read
Feb 2023
AdvisorAction Potential Venture Capital
Oct 2019 to Jul 2025
Advisory Board MemberCareMessage
Jul 2018 to Jul 2025
Advisory Board MemberSounding Board (a BTS company)
Apr 2019 to Mar 2025
Board of DirectorsNevro
May 2016 to Mar 2019
President and Chief Executive OfficerNevro
Nov 2012 to Mar 2019
Board of DirectorsNevro
Jul 2011 to Oct 2012
Board Of DirectorsZeo, Inc.
Nov 2010 to Nov 2012
Board of DirectorsArstasis
May 2012 to Oct 2012
Board of DirectorsTheravent, Inc.
Apr 2011 to Oct 2012
Board of DirectorsCardiac Dimensions
Jan 2011 to Oct 2012
Principal, Venture InvestmentsJohnson & Johnson
Sep 2008 to Oct 2012
Summer Associate, Venture InvestmentsJohnson & Johnson
May 2007 to Jul 2007

Education

The Wharton School
MBA, Health Care Management, Management
2006 to 2008